| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10091615 | The Journal of Pediatrics | 2005 | 5 Pages |
Abstract
A cost-benefit analysis of CF multi-mutation testing is warranted. The study of health care cost data is complex and utilization varies between children. Individual-level modeling of CF costs must include factors contributing to the severity of the disease and allow for consideration of individual-level utilization, such as the number of hospitalizations.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Marjorie A. PhD, FSA, Philip M. MD, PhD,